Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$706.23
-0.2%
$606.17
$437.37
$714.30
$217.17B1.352.39 million shs3.30 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$155.81
+2.0%
$153.63
$140.68
$169.99
$367.53B0.418.05 million shs10.89 million shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
-0.32%+6.72%+17.73%+25.16%+52.32%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+2.12%+2.33%+0.53%+0.26%+6.41%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
4.8519 of 5 stars
2.23.04.23.02.23.33.1
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.849 of 5 stars
2.35.04.23.93.11.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
2.33
Hold$595.67-15.66% Downside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.55
Moderate Buy$170.889.67% Upside

Current Analyst Ratings Breakdown

Latest JNJ and GS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/23/2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$570.00 ➝ $592.00
6/5/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$181.00
5/13/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
5/13/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform$169.00 ➝ $153.00
4/24/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/17/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$166.00 ➝ $165.00
4/16/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
4/16/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$181.00 ➝ $181.00
4/16/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$164.00 ➝ $169.00
4/15/2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$610.00 ➝ $560.00
4/15/2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$680.00 ➝ $650.00
(Data available from 7/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$126.85B1.71$53.58 per share13.18$350.27 per share2.02
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B4.22$13.39 per share11.64$29.69 per share5.25
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$14.28B$43.0916.3913.560.9711.86%13.76%0.87%7/16/2025 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$8.9917.3314.072.3124.42%33.46%13.30%7/16/2025 (Estimated)

Latest JNJ and GS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/16/2025Q2 2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$9.82N/AN/AN/A$13.53 billionN/A
7/16/2025Q2 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.65N/AN/AN/A$22.85 billionN/A
4/15/2025Q1 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.59$2.77+$0.18$4.54$21.65 billion$21.89 billion
4/14/2025Q1 2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$12.57$14.12+$1.55$14.12$14.99 billion$15.06 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$12.001.70%N/A27.85%13 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.203.34%N/A57.84%64 Years

Latest JNJ and GS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/15/2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
quarterly$3.002.3%5/30/20255/30/20256/27/2025
4/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.303.37%5/27/20255/27/20256/10/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
2.41
0.68
0.68
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.49
1.26
1.03

Institutional Ownership

CompanyInstitutional Ownership
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
71.21%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%

Insider Ownership

CompanyInsider Ownership
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
0.55%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
CompanyEmployeesShares OutstandingFree FloatOptionable
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
46,500306.84 million305.15 millionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,1002.41 billion2.40 billionOptionable

Recent News About These Companies

AI builds ideal dividend stock portfolio for H2 2025
Johnson & Johnson: Patience Will Be Rewarded

New MarketBeat Followers Over Time

Media Sentiment Over Time

The Goldman Sachs Group stock logo

The Goldman Sachs Group NYSE:GS

$706.23 -1.52 (-0.21%)
Closing price 07/1/2025 03:59 PM Eastern
Extended Trading
$707.30 +1.06 (+0.15%)
As of 07/1/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements. This segment also offers client execution activities for cash and derivative instruments; credit and interest rate products; and provision of mortgages, currencies, commodities, and equities related products, as well as underwriting services. The Asset & Wealth Management segment manages assets across various classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, wealth advisory services, personalized financial planning, and private banking services, as well as invests in corporate equity, credit, real estate, and infrastructure assets. The Platform Solutions segment offers credit cards and point-of-sale financing for purchase of goods or services. This segment also provides cash management services, such as deposit-taking and payment solutions for corporate and institutional clients. The Goldman Sachs Group, Inc. was founded in 1869 and is headquartered in New York, New York.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$155.81 +3.06 (+2.00%)
Closing price 07/1/2025 03:59 PM Eastern
Extended Trading
$155.80 0.00 (0.00%)
As of 07/1/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.